GlaxoSmithKline Plans a £500 Million ($779 Million) Patent Pill And New Facility; 1,000 Jobs to be Created Over Lifetime of Projects

LONDON, Nov 29 (Reuters) - GlaxoSmithKline Plc (GSK.L) is pushing ahead with plans to invest 500 million pounds ($779 million) in British manufacturing after the government pledged support for a new tax incentive scheme to promote innovation.